CHU de Bordeaux Hop St ANDRE ( Site 5607) — Bordeaux, Gironde

Public research footprint of CHU de Bordeaux Hop St ANDRE ( Site 5607), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Renal Cell Carcinoma · Small Cell Lung Cancer · Biliary Tract Cancer · Carcinoma, Transitional Cell

Recently updated registry entries

NCT07227402 — A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer… (Recruiting)
NCT07106762 — Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic… (Recruiting)
NCT02711553 — A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Bordeaux Hop St ANDRE ( Site 5607)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.